Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DNAtix is a genetics-focused biotechnology company that developed a blockchain-based ecosystem for genomic data management and analysis. The company's platform was designed to allow users to store, transfer, and analyze their genetic information anonymously while maintaining full ownership of their data. DNAtix aimed to create a decentralized marketplace where researchers and healthcare providers could access genetic data for clinical studies through a secure infrastructure. Their core technology included proprietary DNA compression algorithms specifically engineered to enable the transfer of large genomic files over blockchain networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Digital DNAtix.